The Small-Molecule E26-Transformation-Specific Inhibitor TK216 Attenuates the Oncogenic Properties of Pediatric Leukemia
The E26-transformation-specific (ETS) transcription factors regulate multiple aspects of the normal hematopoietic system. There is an increasing body of evidence suggesting aberrant ETS activity and its contribution to leukemia initiation and progression. In this study, we evaluated the small-molecu...
Main Authors: | Ritul Sharma, Chunfen Zhang, Aru Narendran |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-10-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/14/10/1916 |
Similar Items
-
Down-Regulation of PU.1 Gene in Pediatric Acute Lymphoblastic Leukemia Patients from South of Iran
by: Bita Nakhost, et al.
Published: (2019-01-01) -
FAT1 Gene Expression in Iranian Acute Lymphoid and Myeloid Leukemia Patients
by: Mohammadreza Ostadali Dehaghi, et al.
Published: (2023-04-01) -
Role of radiotherapy in treatment of extramedullary relapse following total marrow and lymphoid irradiation in high-risk and/or relapsed/refractory acute leukemia
by: Colton Ladbury, et al.
Published: (2022-10-01) -
The Newly Identified T Helper 22 Cells Lodge in Leukemia
by: Gholamreza Azizi, et al.
Published: (2015-09-01) -
Antibody–Drug Conjugates for the Treatment of Acute Pediatric Leukemia
by: Jamie L. Stokke, et al.
Published: (2021-08-01)